Cohen Fred E Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
2
Insider Sells Sum
$2.67M

Insider Activity of Cohen Fred E

According to the SEC Form 4 filings, Cohen Fred E, being in a position of

  1. director at Intellia Therapeutics, Inc.,
    оver the last 12 months, has bought 150000 shares for $1.4M, and sold 0 shares,
    over all time since 2026-01-05, has bought 150000 shares for $1.4M, and sold 0 shares.

Biography of Cohen Fred E

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $1,402,5001100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-01-05PurchaseIntellia Therapeutics, Inc.
NTLA
director
150,000
0.1428%
$9.35$1.4M+36.93%
2020-05-18SaleVeracyte, Inc.
VCYT
director
80,000
0.1631%
$26.86$2.15M+63.15%
2017-09-18SaleBioCryst Pharmaceuticals, Inc.
BCRX
director
108,500
0.1161%
$4.84$525,683-3.04%
Total: 3
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.